Neuropsychological Norms for Ethnically Diverse Florida Elders
Study Details
Study Description
Brief Summary
The goal of this proposal is to collect normative data from a sample of ethnically diverse Florida elders on a brief, standardized neuropsychological test battery . The norms collected in this multi-cultural dataset will provide appropriate corrections for demographic and sociocultural variables that contribute to performance variance on neuropsychological tests. By accounting for these variables, the normative corrections will improve specificity and eliminate disparities in diagnostic validity and clinical utility of neuropsychological tests when administered to Florida's ethnic minority elders.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Caucasian English speaking Caucasian individuals |
Other: Neuropsychological Testing
Each group will be administered a battery of neuropsychological tests
|
African American English speaking African American individuals |
Other: Neuropsychological Testing
Each group will be administered a battery of neuropsychological tests
|
Hispanic Spanish speaking Hispanic individuals |
Other: Neuropsychological Testing
Each group will be administered a battery of neuropsychological tests
|
Outcome Measures
Primary Outcome Measures
- Neuropsychological norms [1 year]
Norm referenced scores from the sample population
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Age 60 or above.
-
Any gender.
-
Primary language of English or Spanish.
-
Self-identifies as Hispanic, non-Hispanic Black/African American, or non-Hispanic Caucasian.
-
Global Clinical Dementia Rating (CDR) score = 0.
Exclusion Criteria:
-
Memory decline reported by participant, informant (if available), or study clinician.
-
Currently uncontrolled health condition that could affect cognition.
-
Abnormal findings on current neurologic examination.
-
History of chronic neurological diseases (stroke, active seizure disorder, parkisonism, TBI with subsequent cognitive change.
-
Current substance abuse or history of substance dependence.
-
History of chronic psychiatric disease (Bipolar disorder, schizophrenia).
-
Currently active mood disorder. History of depression or anxiety is acceptable if symptoms are controlled (Score <6 on the Geriatric Depression Scale). If taking psychoactive mood medication dosage must be stable for at least one month prior to testing.
-
Use of cognitive enhancing medications (i.e. cholinesterase inhibitors, memantine).
-
Need for assistance in activities of daily living due to cognitive reasons.
-
Sensorimotor deficits that would interfere with ability to perform neuropsychological tests.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Mayo Clinic Florida | Jacksonville | Florida | United States | 32224 |
2 | Mt. Sinai Medical Center | Miami | Florida | United States | 33136 |
3 | University of South Florida | Tampa | Florida | United States | 33612 |
Sponsors and Collaborators
- University of South Florida
- Mayo Clinic
- Mt. Sinai Medical Center, Miami
- Florida Department of Health
Investigators
- Principal Investigator: John Lucas, Ph.D, Mayo Clinic
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- FloridaElderNorms